this post was submitted on 09 May 2025
213 points (99.5% liked)

News

36599 readers
1547 users here now

Welcome to the News community!

Rules:

1. Be civil


Attack the argument, not the person. No racism/sexism/bigotry. Good faith argumentation only. This includes accusing another user of being a bot or paid actor. Trolling is uncivil and is grounds for removal and/or a community ban. Do not respond to rule-breaking content; report it and move on.


2. All posts should contain a source (url) that is as reliable and unbiased as possible and must only contain one link.


Obvious biased sources will be removed at the mods’ discretion. Supporting links can be added in comments or posted separately but not to the post body. Sources may be checked for reliability using Wikipedia, MBFC, AdFontes, GroundNews, etc.


3. No bots, spam or self-promotion.


Only approved bots, which follow the guidelines for bots set by the instance, are allowed.


4. Post titles should be the same as the article used as source. Clickbait titles may be removed.


Posts which titles don’t match the source may be removed. If the site changed their headline, we may ask you to update the post title. Clickbait titles use hyperbolic language and do not accurately describe the article content. When necessary, post titles may be edited, clearly marked with [brackets], but may never be used to editorialize or comment on the content.


5. Only recent news is allowed.


Posts must be news from the most recent 30 days.


6. All posts must be news articles.


No opinion pieces, Listicles, editorials, videos, blogs, press releases, or celebrity gossip will be allowed. All posts will be judged on a case-by-case basis. Mods may use discretion to pre-approve videos or press releases from highly credible sources that provide unique, newsworthy content not available or possible in another format.


7. No duplicate posts.


If an article has already been posted, it will be removed. Different articles reporting on the same subject are permitted. If the post that matches your post is very old, we refer you to rule 5.


8. Misinformation is prohibited.


Misinformation / propaganda is strictly prohibited. Any comment or post containing or linking to misinformation will be removed. If you feel that your post has been removed in error, credible sources must be provided.


9. No link shorteners or news aggregators.


All posts must link to original article sources. You may include archival links in the post description. News aggregators such as Yahoo, Google, Hacker News, etc. should be avoided in favor of the original source link. Newswire services such as AP, Reuters, or AFP, are frequently republished and may be shared from other credible sources.


10. Don't copy entire article in your post body


For copyright reasons, you are not allowed to copy an entire article into your post body. This is an instance wide rule, that is strictly enforced in this community.

founded 2 years ago
MODERATORS
 

Far fewer babies went to the hospital struggling to breathe from RSV, a severe respiratory infection, after the debut of a new vaccine and treatment this season, according to an analysis published today by the Centers for Disease Control and Prevention.

RSV, or respiratory syncytial (sin-SISH-uhl) virus, is the leading cause of hospitalization for infants in the US. An estimated 58,000–80,000 children younger than 5 years old are hospitalized each year. Newborns—babies between 0 and 2 months—are the most at risk of being hospitalized with RSV. The virus circulates seasonally, typically rising in the fall and peaking in the winter, like many other respiratory infections.

But the 2024–2025 season was different—there were two new ways to protect against the infection. One is a maternal vaccine, Pfizer's Abrysvo, which is given to pregnant people when their third trimester aligns with RSV season (generally September through January). Maternal antibodies generated from the vaccination pass to the fetus in the uterus and can protect a newborn in the first few months of life. The other new protection against RSV is a long-acting monoclonal antibody treatment, nirsevimab, which is given to babies under 8 months old as they enter or are born into their first RSV season and may not be protected by maternal antibodies.

you are viewing a single comment's thread
view the rest of the comments
[–] Ledericas@lemm.ee 3 points 10 months ago (2 children)

i think most adults are exposed to RSV, the vaccine is rpetty new and its not offered to adults commonly.

[–] NotMyOldRedditName@lemmy.world 1 points 10 months ago* (last edited 10 months ago)

Pretty much everyone has had it, but it does mutate and we can be reinfected as adults. It's not offered to your typical healthy adult, but it'd be nice if they would.

[–] MagicShel@lemmy.zip 1 points 10 months ago

You're partially right and I was misremembering. There is an RSV vaccine but it's typically only given to older adults and people who have had severe RSV, which my dad recently did and we were discussing that he would need the vaccine.

We just recently got every vaccine under the sun and my brain jumbled those things around. I got pneumonia, flu, Covid, TDAP, and Hep B. I always forget that last one because most of my life that was only for IV drug users and it's weird to me that it's for everyone now. So I counted and thought RSV. Thanks for setting that straight.